4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-023022
Chief Financial Officer sold 4,156 shares at $3.70 ($15,382)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NOUGUES MAXIMO F Chief Financial Officer | 2024-07-17 | Sale 10b5-1 | −4,156 | $3.70 | $15,382 | 162,522 | D |
| Open-market sales · 4,156 sh · avg $3.70 · $15,382 | |||||||
Loading xslF345X05/rdgdoc.xml…